Mycophenolate mofetil and Dasatinib drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Dasatinib (dasatinib). Common drug interactions include cystitis haemorrhagic among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Dasatinib. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,461 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Dasatinib?

Dasatinib has active ingredients of dasatinib. eHealthMe is studying from 9,407 Dasatinib users. Check the latest studies of Dasatinib.

On Aug, 09, 2026

87 people who take Mycophenolate mofetil and Dasatinib together, and have interactions are studied.

Mycophenolate mofetil and Dasatinib drug interactions.

What are the common drug interactions of Mycophenolate Mofetil and Dasatinib, by gender? *:

female:

Cystitis haemorrhagic (blood in the urine and painful voiding)
Cytomegalovirus viraemia (cytomegalo virus in blood stream)
Diarrhoea
Dry eye (lack of adequate tears)
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Erythema (redness of the skin)
Eschar (dead tissue that falls off (sheds) from healthy skin)
Febrile neutropenia (fever with reduced white blood cells)
Feeling cold
Gangrene (body tissue dies)

male:

Drug ineffective
Pleural effusion (water on the lungs)
Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
Cytomegalovirus infection
Blood creatinine increased
Disease progression
Encephalitis (inflammation of the brain)
Febrile neutropenia (fever with reduced white blood cells)
Human herpesvirus 6 infection
Hypokalaemia (low potassium)

What are the common drug interactions of Mycophenolate Mofetil and Dasatinib, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood)
Congestive cardiomyopathy (weakening of heart muscle)

10-19:

Drug ineffective
Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
Pneumonia
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
Blood creatinine increased
Encephalitis (inflammation of the brain)
Febrile neutropenia (fever with reduced white blood cells)
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Human herpesvirus 6 infection
Hypokalaemia (low potassium)

20-29:

Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
Central nervous system leukaemia (cancer of central nervous system)
Cystitis haemorrhagic (blood in the urine and painful voiding)
Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Pneumonia cytomegaloviral (cmv pneumonia is caused by a member of a group of herpes-type viruses)
Bk virus infection
Cytomegalovirus infection
B precursor type acute leukaemia (lymphoid cancer)
Blindness unilateral

30-39:

Drug ineffective
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Disease progression
Foreign body sensation in eyes (feeling of something in eye)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)
Skin hyperpigmentation (disorders affect the colour of your skin)
Skin ulcer
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Drug resistance (reduction in effectiveness of a drug)

40-49:

Oedema peripheral (superficial swelling)
Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
Chronic graft versus host disease (immune cells attack the host's body cells after transplant)
Fatigue (feeling of tiredness)
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Acarodermatitis (skin inflammation caused by mites (acarids))
Anxiety
Asthenia (weakness)
Blood potassium increased
Decreased appetite

50-59:

Venoocclusive liver disease (small veins in the liver are obstructed)
Drug ineffective
Hepatic failure (liver failure)
Neutropenia (an abnormally low number of neutrophils)
Thrombocytopenia (decrease of platelets in blood)
Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood)
Disease progression
Gastrointestinal stromal tumour (a cancer that arises from transformed cells of mesenchymal origin in gastrointestinal tract)
Platelet count decreased
Pneumomediastinum (air is present in the mediastinum)

60+:

Pericardial effusion (fluid around the heart)
Pleural effusion (water on the lungs)
Febrile neutropenia (fever with reduced white blood cells)
Infection
Pneumonia
Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
Drug ineffective
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Post transplant lymphoproliferative disorder

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 32 people, 36.78%
Bone Marrow Conditioning Regimen: 20 people, 22.99%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 11 people, 12.64%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 8 people, 9.20%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 6 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and Dasatinib?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously